Results
1
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
1 companies
Cogstate
Market Cap: AU$301.4m
A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry-sponsored research.
CGS
AU$1.78
7D
5.0%
1Y
87.4%